You are here: Industry Insights > Pfizer

News List

Heart Issue Spotted in a Few Young COVID Vaccine Recipients drugs
May 25, 2021
A small number of teens and young adults have experienced heart inflammation after receiving mRNA COVID-19 vaccines produced by Pfizer and Moderna, the U.S. Centers for Disease Control and Prevention reports.
EC to procure 1.8 billion doses of Pfizer-BioNTech’s Covid-19 vaccine pharmaceutical-technology
May 24, 2021
The European Commission (EC) has signed a new contract with BioNTech and Pfizer to procure additional 1.8 billion doses of their Covid-19 vaccine, Comirnaty, between this year end to 2023.
India, Pfizer discuss vaccine deal, seek to resolve dissension over vaccine indemnity: Report expresspharma
May 24, 2021
India has not given any manufacturer of a COVID-19 vaccine indemnity against the costs of compensation for any severe side effects, which is a condition Pfizer has obtained in many countries.
Pfizer, BioNTech to Supply Additional COVID-19 Vax Doses to Turkey contractpharma
May 21, 2021
Pfizer and BioNTech Europe GmbH have entered an agreement with Turkey’s Ministry of Health to supply 60 million additional doses of the companies’ COVID-19 vaccine, with an option for an additional 30 million doses.
Pfizer, BioNTech to Supply EU with Additional COMIRNATY Doses contractpharma
May 21, 2021
Pfizer and BioNTech SE entered a new agreement with the European Commission (EC) to supply 900 million doses of COMIRNATY, the companies’ COVID-19 vaccine, to the EU, with an option for the EC to request up to an additional 900 million doses.
Spanish study finds AstraZeneca vaccine followed by Pfizer dose is safe and effective expresspharma
May 20, 2021
The presence of neutralising antibodies rose sevenfold after a Pfizer dose, significantly more than the doubling effect observed after a second AstraZeneca shot.
Pfizer enrols first UK participant into global DMD gene therapy study pharmatimes
May 14, 2021
Pfizer has announced that it has enrolled the first UK participant in a global Phase III study aiming to evaluate its investigational gene therapy candidate in boys with Duchenne muscular dystrophy (DMD).
NICE rejects Pfizer’s rare heart disease treatment Vyndaqel pharmatimes
May 13, 2021
Pfizer’s Vyndaqel has been rejected by the UK National Institute for Health and Care Excellence (NICE) as a treatment for the rare heart condition transthyretin amyloidosis with cardiomyopathy (ATTR-CM).
Pfizer, BioNTech get US FDA nod for emergency use of COVID-19 vaccine in adolescents expresspharma
May 12, 2021
Pfizer and BioNTech SE announced that the US Food and Drug Administration (FDA) has expanded the Emergency Use Authorization (EUA) for their COVID-19 vaccine to include individuals 12 to 15 years of age.
Pfizer and BioNTech to provide COVID-19 vaccine doses for olympic athletes at the 2020 Tokyo Games worldpharmanews
May 11, 2021
Pfizer Inc. and BioNTech SE announced the signing of a Memorandum of Understanding (MoU) with the International Olympic Committee (IOC) to donate doses of the companies' COVID-19 Vaccine to help vaccinate athletes, and their delegations, participating ...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page